ESC Premium Access

Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Congress Session

About the speaker

Doctor Lili Xu

Zhongshan Hospital, Shanghai (China)
0 follower

19 more presentations in this session

Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes

Speaker: Mr S. Mohammed (Zurich, CH)

Thumbnail

Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis

Speaker: Ms K. Tkacz (Cracow, PL)

Thumbnail

New insights into the development of radiation-induced cardiac damage using a mouse model

Speaker: Doctor S. Mrotzek (Essen, DE)

Thumbnail

The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension via targeting PTEN

Speaker: Doctor Y. Qin (Nanjing, CN)

Thumbnail

Senescent endothelial cells exacerbate pulmonary hypertension through notch-mediated juxtacrine interaction with pulmonary artery smooth muscle cells

Speaker: Doctor R. Ramadhiani (Kobe, JP)

Thumbnail

Access the full session

Congress committee e-posters choice in basic science

Speakers: Doctor L. Xu, Mr S. Mohammed, Ms K. Tkacz, Doctor S. Mrotzek, Doctor Y. Qin...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The ADDition of DAPAgliflozin to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory HFrEF

27 August 2021

ESC Premium Access

Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA)

27 August 2021

ESC Premium Access

Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial

27 August 2021

This platform is supported by

logo Novo Nordisk